Ross Osborn Stock Analyst Profile - Cantor Fitzgerald Research Coverage - Stocknear

Ross Osborn

Stock Analyst at Cantor Fitzgerald

(3.36)
# 2741
Out of 5,493 analysts
127
Total ratings
Success rate
Average return

25 Stocks

Name Action PT Current % Upside Ratings Updated
ORGO Organogenesis Holdin...
Maintains: Overweight
7 9
4.1 119.51% 4 Aug 8, 2025
LMAT LeMaitre Vascular
Maintains: Neutral
92 95
84.19 12.84% 2 Aug 6, 2025
CVRX CVRx
Reiterates: Overweight
11 11
7.55 45.7% 3 Aug 5, 2025
SIBN SI-BONE
Reiterates: Overweight
25 25
14.05 77.94% 10 Aug 5, 2025
MDXG MiMedx Group
Maintains: Overweight
11 12
6.94 72.91% 5 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
12
6.66 80.18% 1 Jul 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
8 7
10.89 -35.72% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
2 2
1.03 94.17% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
17 17
10.2 66.67% 7 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
12 9
3.72 141.94% 11 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
46 46
31.85 44.43% 6 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8 8
0.99 708.08% 10 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
24 24
17.16 39.86% 3 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.44 177.78% 4 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
9 9
12.59 -28.51% 7 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
4.29 109.79% 1 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
21 21
5.2 303.85% 10 Dec 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
16 16
4.45 259.55% 4 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.21 189.26% 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
0.59 323.73% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 7 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
4 4
n/a n/a 5 Apr 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
9
n/a n/a 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 21
n/a n/a 2 Apr 22, 2022